Special Issue "Marine Drugs Studies in China"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 January 2009)

Special Issue Editors

Managing Editor
Dr. Shu-Kun Lin
MDPI AG, Postfach, CH-4005 Basel, Switzerland. Office: Kandererstrasse 25, 4057 Basel
Website: http://www.mdpi.org/lin/
E-Mail: lin@mdpi.com
Phone: +41 61 683 77 34
Fax: +41 61 302 89 18
Interests: Gibbs paradox; entropy; symmetry; similarity; diversity; information theory; thermodynamics; process irreversibility or spontaneity; stability; nature of the chemical processes; molecular recognition; open access journals

Assistant Editor
Ms. Tina Wang
MDPI Beijing Office, Liyuanbeijie Road 186, Suite 307, Liyuan Town, Tongzhou District, 101101 Beijing, China
E-Mail: tina.wang@mdpi.com
Phone: +86 10 59011009
Fax: +86 10 59011089

Special Issue Information

Submission

All papers should be submitted to marinedrugs@mdpi.com with copy to the Editors. To be published continuously until the deadline and papers will be listed together at the special websites. Both, research articles and review articles are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editors for announcment on this website.

Submitted papers should not have been published previously, nor be under consideration for publication elsewhere. All papers are refereed through a peer-review process. A guide for authors, sample copies and other relevant information for submitting papers are available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a paper. Open Access publication fees are 1000 CHF per paper. English correction fees (250 CHF) will be added in certain cases (1250 CHF per paper for those papers that require extensive additional formatting and/or English corrections.).

Keywords

marine drugs related research in the P. R. China

Published Papers (2 papers)

Open Access
Mar. Drugs 2009, 7(1), 24-44; doi:10.3390/md7010024
Received: 11 December 2008; in revised form: 12 January 2009 / Accepted: 21 January 2009 / Published: 3 January 2009
Show/Hide Abstract | Download PDF Full-text (542 KB) | Supplementary Files

Open Access
Mar. Drugs 2009, 7(1), 9-18; doi:10.3390/md7010009
Received: 19 September 2008; in revised form: 29 October 2008 / Accepted: 11 December 2008 / Published: 14 January 2009
Show/Hide Abstract | Download PDF Full-text (278 KB)

Planned Papers

Title: Advances in marine symbiotic microorganisms and related pharmaceutical metabolites in China
Author: Zhiyong Li
Affiliation: Laboratory of Marine Biotechnology and Key Laboratory of Microbial Metabolism, Ministry of Education, School of Life Science and Biotechnology, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P.R.China; E-mail: zyli@sjtu.edu.cn; Tel.: (+86)21-34204036
Abstract: Marine plants and animals, such as sponge, sea squirt, worm, and algae host symbiotic microorganisms with great diversity. Most of the symbiotic microorganisms are host-specific and can be transmitted directly from parent to offspring. Symbiotic microorganisms are possible true producer or take part in the biosynthesis of some bioactive marine natural products isolated from the marine organism hosts. Investigation of the pharmaceutical metabolites will lead to reveal the biosynthesis mechanisms of related natural products and solve the problem of supply limitation in marine drug development. This paper reviews the advances in diversity revelation, isolation, biological activity of marine symbiotic microorganisms and related pharmaceutical metabolites in China.

Last update: 5 October 2008

Mar. Drugs EISSN 1660-3397 Published by MDPI Publishing, Basel, Switzerland RSS E-Mail Table of Contents Alert